Domiciliary Insurance Market 2024 | Size, Top Trends, Growth, Share, Key Drivers | Cigna Group, AIA Group Limited, Allianz SE, AXA SA, Aviva PLC

The Domiciliary Insurance Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Domiciliary Insurance Market:
https://www.thebusinessresearchcompany.com/report/domiciliary-insurance-global-market-report

According to The Business Research Company’s Domiciliary Insurance Global Market Report 2024, The domiciliary insurance market size has grown rapidly in recent years. It will grow from $38.35 billion in 2023 to $44.72 billion in 2024 at a compound annual growth rate (CAGR) of 16.6%. The growth in the historic period can be attributed to homeownership, asset protection, mortgage requirements, disaster awareness, regulatory compliance.

The domiciliary insurance market size is expected to see rapidly grown in the next few years. It will grow to $75.49 billion in 2028 at a compound annual growth rate (CAGR) of 14.0%. The growth in the forecast period can be attributed to changing housing trends, environmental risks, technological advances, personalization and customization, economic conditions. Major trends in the forecast period include aging population, home-based care, telehealth integration, customized policies.

The growing geriatric population is expected to drive the domiciliary insurance market. The population of the world is growing older, with the age group of 65 and above being the fastest growing. For instance, according to World Health Organization, there were about 1 billion people aged 60 years and above in the world. The number is expected to reach 1.4 billion by 2030 and 2.1 billion by 2045. The rise in the geriatric population means a population with more health problems that require constant care and have limited ability to move, which makes them dependent on health services in the comfort of their homes. Moreover, even healthcare providers prefer treating them at home unless there is a major emergency, as these services are expensive. People are opting for domiciliary insurance as a separate policy or along with their health insurance plan to cover these home hospitalization treatment costs, which further contributes towards the growth of the market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=4007&type=smp

The domiciliary insurance market covered in this report is segmented –
1) Domiciliary Insurance Market By Insurance Type: Diseases Insurance, Medical Insurance, Income Protection Insurance, Other Insurance Types
2) Domiciliary Insurance Market By Coverage Type: Lifetime Coverage, Term Coverage
3) Domiciliary Insurance Market By Demographics: Minors, Adults, Senior Citizen
4) Domiciliary Insurance Market By Network: Preferred Provider Organizations (PPOs), Point Of Services (POS), Health Maintenance Organization (HMOs), Exclusive Provider Organizations (EPOs)
5) Domiciliary Insurance Market By Service Provider: Private, Public

Top Major Players

Cigna Group

AIA Group Limited

Allianz SE

AXA SA

Aviva PLC

Major companies operating in the drugs for immunotherapy market are focusing on innovating new products, such as Keytruda (pembrolizumab), to provide reliable services to customers. Keytruda (pembrolizumab) is a type of immunotherapy with a targeted therapy drug called an immune checkpoint inhibitor for adult patients. For Instance, In January 2023, Merck & Co., Inc., a US-based pharmaceutical company, launched Keytruda (pembrolizumab), which was approved by the Food and Drug Administration, a US-based federal agency. Keytruda (pembrolizumab) immunotherapy is used to treat various types of cancer by working with the immune system to help fight cancer cells. KEYTRUDA (pembrolizumab) is approved as an adjuvant treatment for non-small cell lung cancer (NSCLC). This is a significant development in the field of cancer treatment, and it is expected to have a positive impact on the healthcare industry.

The domiciliary insurance market report table of contents includes:

1. Executive Summary

2. Domiciliary Insurance Market Characteristics

3. Domiciliary Insurance Market Trends And Strategies

4. Domiciliary Insurance Market – Macro Economic Scenario

5. Global Domiciliary Insurance Market Size and Growth

……

31. Global Domiciliary Insurance Market Competitive Benchmarking

32. Global Domiciliary Insurance Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Domiciliary Insurance Market

34. Domiciliary Insurance Market Future Outlook and Potential Analysis

35. Appendix